#HCQS 400 mg Tablets

[didanawisgi]

Prophylactic HCQ Protocol

Dr. Simone Gold info@aflds.com

This is not medical advice. Every situation is unique, and every person must check with his or her own physician, especially if you are taking any other medication.

Hydroxychloroquine 400 mg. twice a day on the first day + elemental zinc 50 mg. daily then

Hydroxychloroquine 400 mg. weekly + zinc 50 mg. daily

Hydroxychloroquine tablets in the USA are 200 mg. Two can be taken together at the same time or separated by hours-days, as long as a person takes 400 mg. weekly. Currently there are studies underway to see if 200 mg weekly is sufficient.

This protocol is used across the world. For example, see the country of India in the White Paper (reference 19). In this example, the National Task for the COVID-19 constituted by Indian Council of Medical Research recommendations for HCQ for prophylaxis of SARS-CoV-2 infection for selected individuals.

Wellness Protocol

Dr. Teryn Clark @MdTeryn

https://youtu.be/yJsABSVxY5s

THIS IS NOT MEDICAL ADVICE. Every situation is unique and every person must check with his or her own physician, especially if you are taking any other medication.

Age >15    Age <15

Quercetin 500 mg. twice daily

Zinc 50 mg daily

Vitamin D 2000 Iu daily

Melatonin 3-6 mg. nightly (exclude if <25)Elderberry and Zinc gummies

Zelenko Protocol Dr. Vladamir Zelenko @zevdr

https://youtu.be/xaB9Kvulk7M

Treat patients based on clinical suspicion as soon as possible, preferable within the first 5 days of symptoms. Perform PCR testing but do not withhold treatment pending results.

Risk Stratify Patient

Low-risk patient-Younger than 60, no comorbidities, and no serious symptoms.

High-risk patient-Older than 60, younger than 60 with comorbidities, or serious symptoms.

Treatment Options

Low-risk patient

Rest, oral fluids, Tylenol as needed

Vitamin C 1 gm once a day for 7 days

Quercetin 500 mg. twice a day for 7 days

Elemental Zinc 50 mg. once a day for 7 days

Close follow up with a doctor

High-risk patient

Rest, oral fluids

Tylenol as needed

Elemental Zinc 50 mg. once a day for 7 days

Hydroxychloroquine (HCQ) 200 mg twice a day for 5 to 7 days

Azithromycin 500 mg. once a day for 5 days or doxycycline 100 mg twice a day for 5 to 7 days

Note if HCQ is inaccessible then use Quercetin 500 mg. three times a day in place of HCQ. If HCQ becomes accessible, then switch to HCQ.

Additional treatment options. Should be custom tailored for every patient.

Ivermectin 6 mg. twice a day for 1 day

Budesonide 1 mg/2cc solution via nebulizer twice a day for 7 days

Dexamethasone 6 mg. once a day for 5 to 7 days

Blood thinners (i.e. Eliquis or Xarelto)

Home 02

Home IV fluids

[alinabozo]

[wellerectile]

What is the Conclusion of Hydroxychloroquine on Covid-19 Patient?

Hydroxychloroquine (HCQ) is used to treat malaria and autoimmune diseases such as lupus and rheumatoid arthritis. HCQ has been profoundly politicized in the U.S as a treatment for Covid-19, procuring its name as the most dubious medication to date. HCQ is likewise among the top considered medications in Covid-19. Be that as it may, many examinations keep on giving clashing discoveries. Buy COVID 19 medicine in USA at an affordable price.

 Coronavirus patients treated with the drug hydroxychloroquine within the first two days of admission were more likely to survive than patients who received other treatments, according to the study, which was published online by the International Journal of Infectious Diseases.

 The investigation, which broke down clinical records of 2,541 Covid-19 patients, recommends that hydroxychloroquine can be viable whenever given during the beginning phases of getting the infection and at the correct portion, the scientists said. Different investigations, in any case, haven't found an advantage, and government wellbeing authorities pulled back the medication's approval for crisis use. Buy hydroxychloroquine online that proves to be very effective for Covid-19 patients.

 The enrolment of patients in the hydroxychloroquine group was closed on June 5, 2020, after an interim analysis determined that there was a lack of efficacy. Death within 28 days occurred in 421 patients (27.0%) in the hydroxychloroquine group and in 790 (25.0%) in the usual-care group (rate ratio, 1.09; 95% confidence interval [CI], 0.97 to 1.23; P=0.15). Consistent results were seen in all prespecified subgroups of patients. The results suggest that patients in the hydroxychloroquine group were less likely to be discharged from the hospital alive within 28 days than those in the usual-care group (59.6% vs. 62.9%; rate ratio, 0.90; 95% CI, 0.83 to 0.98). Among the patients who were not undergoing mechanical ventilation at baseline, those in the hydroxychloroquine group had a higher frequency of invasive mechanical ventilation or death (30.7% vs. 26.9%; risk ratio, 1.14; 95% CI, 1.03 to 1.27). There was a small numerical excess of cardiac deaths (0.4 percentage points) but no difference in the incidence of new major cardiac arrhythmia among the patients who received hydroxychloroquine.

 Among patients hospitalized with Covid-19, those who received hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care. The one who is corona positive is highly preferred to buy COVID 19 medicine in USA. Earlier this year, hospitals and doctors world-wide began treating Covid-19 patients with hydroxychloroquine, and a similar drug, chloroquine, after several small studies suggested a benefit. Both drugs were approved decades ago to treat and prevent malaria but have also been used for other ailments, such as lupus and rheumatoid arthritis.

 In the hydroxychloroquine group, patients received hydroxychloroquine sulphate (in the form of a 200-mg tablet containing a 155-mg base equivalent) in a loading dose of four tablets (total dose, 800 mg) at baseline and at 6 hours, which was followed by two tablets (total dose, 400 mg) starting at 12 hours after the initial dose and then every 12 hours for the next 9 days or until discharge, whichever occurred earlier. The assigned treatment was prescribed by the attending clinician. The patients and local trial staff members were aware of the assigned trial groups.

[alinabozo]